|
2025 Journal Article Development of Methods to Produce SARS CoV-2 Virus-Like Particles at ScaleEdeling, Melissa A., Earnest, Linda, Carrera Montoya, Julio, Yap, Ashley Huey Yiing, Mumford, Jamie, Roberts, Jason, Wong, Chinn Yi, Hans, Dhiraj, Grima, Joseph, Bisset, Nicole, Bodle, Jesse, Rockman, Steven and Torresi, Joseph (2025). Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale. Biotechnology and Bioengineering, 122 (5), 1118-1129. doi: 10.1002/bit.28937 |
|
2024 Journal Article Prolonged vs intermittent infusions of β-lactam antibiotics-replyRoberts, Jason A., Devaux, Anthony and Abdul-Aziz, Mohd H. (2024). Prolonged vs intermittent infusions of β-lactam antibiotics-reply. JAMA-Journal of the American Medical Association, 333 (3), 259. doi: 10.1001/jama.2024.23728 |
|
2024 Journal Article A pooled pharmacokinetic analysis for piperacillin/tazobactam across different patient populations: From premature infants to the elderlyKong, Daming, Roberts, Jason A., Lipman, Jeffrey, Taccone, Fabio Silvio, Cohen-Wolkowiez, Michael, Sime, Fekade B., Tsai, Danny, De Cock, Pieter A. J. G., Jaruratanasirikul, Sutep, Dhaese, Sofie A. M., Udy, Andrew A., Felton, Timothy W., Michelet, Robin, Thibault, Celine, Koomen, Jeroen V., Eleveld, Douglas J., Struys, Michel M. R. F., De Waele, Jan J., Colin, Pieter J., Damen, Caroline and PIP/TAZ Consortium (2024). A pooled pharmacokinetic analysis for piperacillin/tazobactam across different patient populations: From premature infants to the elderly. Clinical Pharmacokinetics, 64 (1) 769329, 107-126. doi: 10.1007/s40262-024-01460-6 |
|
2024 Journal Article Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patientsKumta, Nilesh, Heffernan, Aaron J., Cotta, Menino Osbert, Liu, Xin, Parker, Suzanne, Wallis, Steven, Livermore, Amelia, Starr, Therese, Wong, Wai Tat, Joynt, Gavin M., Lipman, Jeffrey and Roberts, Jason A. (2024). Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients. Antimicrobial Agents and Chemotherapy, 69 (2), e0060124. doi: 10.1128/aac.00601-24 |
|
2024 Journal Article A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteriaAssefa, Getnet M., Roberts, Jason A., Aslan, Abdullah T., Mohammed, Solomon A. and Sime, Fekade B. (2024). A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy, 80 (2), 334-346. doi: 10.1093/jac/dkae451 |
|
2024 Journal Article Continuous vs intermittent β-lactam antibiotic infusions for sepsis-ReplyDulhunty, Joel M., Roberts, Jason A. and Lipman, Jeffrey (2024). Continuous vs intermittent β-lactam antibiotic infusions for sepsis-Reply. JAMA: The Journal of the American Medical Association, 333 (2), 174-175. doi: 10.1001/jama.2024.23275 |
|
2024 Journal Article Considerations for β-lactam antimicrobial continuous infusion. Authors’ reply to Massart et al. and Marzaroli et alBarton, Greg, Rickard, Claire M. and Roberts, Jason A. (2024). Considerations for β-lactam antimicrobial continuous infusion. Authors’ reply to Massart et al. and Marzaroli et al. Intensive Care Medicine, 51 (1), 230-231. doi: 10.1007/s00134-024-07724-w |
|
2024 Journal Article Dynamic in vitro PK/PD infection models for the development and optimisation of antimicrobial regimens: A narrative reviewWale, Yalew M., Roberts, Jason A. and Sime, Fekade B. (2024). Dynamic in vitro PK/PD infection models for the development and optimisation of antimicrobial regimens: A narrative review. Antibiotics, 13 (12) 1201, 1-23. doi: 10.3390/antibiotics13121201 |
|
2024 Journal Article Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections in Central AustraliaLangham, Freya, Tsai, Danny, Forde, Brian M., Camilleri, Shayne, Harris, Patrick N.A., Roberts, Jason A. and Chiong, Fabian (2024). Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections in Central Australia. Pathology, 56 (7), 1012-1020. doi: 10.1016/j.pathol.2024.04.013 |
|
2024 Journal Article Renal function and its impact on the concentration of ceftazidime-avibactam: a cross-sectional studyLanini, Simone, Giuliano, Simone, Angelini, Jacopo, Ferin, Sara, Martini, Luca, Baraldo, Massimo, Cossettini, Stella, Roberts, Jason and Tascini, Carlo (2024). Renal function and its impact on the concentration of ceftazidime-avibactam: a cross-sectional study. International Journal of Antimicrobial Agents, 64 (6) 107351, 1-6. doi: 10.1016/j.ijantimicag.2024.107351 |
|
2024 Journal Article The long-term sustainability of a pharmacist-led antimicrobial stewardship penicillin allergy delabelling ward round: A prospective cohort studyMitri, Elise, Vogrin, Sara, Chua, Kyra Y.L., Copaescu, Ana-Maria, Waldron, Jamie, Cox, Fionnuala, Devchand, Misha, Hall, Rebecca, McInnes, Kerryn, Holmes, Natasha E., Ierano, Courtney, Roberts, Jason A., Fernando, Suran L., Reynolds, Gemma K. and Trubiano, Jason A. (2024). The long-term sustainability of a pharmacist-led antimicrobial stewardship penicillin allergy delabelling ward round: A prospective cohort study. CMI Communications, 1 (3) 105055, 1-5. doi: 10.1016/j.cmicom.2024.105055 |
|
2024 Journal Article Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection modelAbbott, Iain J., Anderson, Connor R. B., van Gorp, Elke, Wallis, Steve C., Roberts, Jason A., Meletiadis, Joseph and Peleg, Anton Y. (2024). Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model. Journal of Antimicrobial Chemotherapy, 80 (2), 413-426. doi: 10.1093/jac/dkae424 |
|
2024 Journal Article A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?Naicker, Saiyuri, Roberts, Jason A., Cheng, Vesa, Parker, Suzanne L., Seaton, R. Andrew, Gilchrist, Mark and Sime, Fekade B. (2024). A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?. JAC-Antimicrobial Resistance, 6 (6) dlae186, 1-11. doi: 10.1093/jacamr/dlae186 |
|
2024 Journal Article Is it time to implement prolonged infusions of beta-lactam antibiotics in and beyond critical care settings?Abdul-Aziz, Mohd H., Dulhunty, Joel M., Rajbhandari, Dorrilyn, Roberts, Jason A. and Lipman, Jeffrey (2024). Is it time to implement prolonged infusions of beta-lactam antibiotics in and beyond critical care settings?. Internal Medicine Journal, 54 (12), 1931-1934. doi: 10.1111/imj.16584 |
|
2024 Journal Article Outpatient parenteral antimicrobial therapy with carbapenems: a systematic reviewWolie, Z. T., Roberts, J. A., Wale, Y. M., Unwin, S., McCarthy, K. and Sime, F. B. (2024). Outpatient parenteral antimicrobial therapy with carbapenems: a systematic review. Journal of Infection, 89 (5) 106299, 106299. doi: 10.1016/j.jinf.2024.106299 |
|
2024 Journal Article Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?Duke, Carleigh, Parker, Suzanne L., Zam, Betty B., Chiong, Fabian, Sajiv, Cherian, Pawar, Basant, Ashok, Aadith, Cooper, Brynley P., Tong, Steven Y. C., Janson, Sonja, Wallis, Steven C., Roberts, Jason A. and Tsai, Danny (2024). Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?. Journal of Antimicrobial Chemotherapy, 79 (11), 2980-2989. doi: 10.1093/jac/dkae318 |
|
2024 Conference Publication Sequestration of common antibiotics onto a pediatric extracorporeal membrane oxygenation (ECMO) circuit? An ex-vivo studyCree, Michele, Haisz, E., Wallis, S., Schlapbach, L., Roberts, J. and Parker, S. (2024). Sequestration of common antibiotics onto a pediatric extracorporeal membrane oxygenation (ECMO) circuit? An ex-vivo study. 12th World Congress on Pediatric Intensive and Critical Care, Cancun, Mexico, 1-5 June 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.pcc.0001085588.32445.76 |
|
2024 Conference Publication Does renal replacement therapy (RRT) circuitry remove common antibiotics? An ex-vivo study simulating pediatric treatmentCree, Michele, Wallis, S., Schlapbach, L., Roberts, J. and Parker, S. (2024). Does renal replacement therapy (RRT) circuitry remove common antibiotics? An ex-vivo study simulating pediatric treatment. 12th World Congress on Pediatric Intensive and Critical Care, Cancun, Mexico, 1-5 June 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.pcc.0001085192.44125.4e |
|
2024 Journal Article Continuous infusion of piperacillin/tazobactam optimizes intraoperative antibiotic exposure in patients undergoing elective pelvic exenteration surgeryJackson, Dwane, Ulldemolins, Marta, Liu, Xin, Harris, Craig, Tognolini, Angela, Wallis, Steven C., Sumi, Chandra, Parker, Suzanne L., Eley, Victoria and Roberts, Jason A. (2024). Continuous infusion of piperacillin/tazobactam optimizes intraoperative antibiotic exposure in patients undergoing elective pelvic exenteration surgery. Antimicrobial Agents and Chemotherapy, 68 (12) e0111624, e0111624. doi: 10.1128/aac.01116-24 |
|
2024 Journal Article Is there evidence on the optimal duration of aminoglycoside therapy in beta-lactam/aminoglycoside combination regimens used for the treatment of Gram-negative bacterial infections? -A Systematic ReviewWale, Yalew M., Roberts, Jason A., Wolie, Zenaw T. and Sime, Fekade B. (2024). Is there evidence on the optimal duration of aminoglycoside therapy in beta-lactam/aminoglycoside combination regimens used for the treatment of Gram-negative bacterial infections? -A Systematic Review. International Journal of Antimicrobial Agents, 64 (4) 107297, 1-12. doi: 10.1016/j.ijantimicag.2024.107297 |
